Edition:
United Kingdom

Voyager Therapeutics Inc (VYGR.OQ)

VYGR.OQ on NASDAQ Stock Exchange Global Select Market

8.26USD
18 Jan 2019
Change (% chg)

$-0.24 (-2.82%)
Prev Close
$8.50
Open
$8.48
Day's High
$8.48
Day's Low
$8.10
Volume
102,808
Avg. Vol
121,839
52-wk High
$31.91
52-wk Low
$8.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 2.09 -0.630
Jun '18 2.58 -0.799
Mar '18 0.94 -0.627
FY 2017 Dec '17 6.34 -0.404
Sep '17 1.15 -0.892
Jun '17 1.18 -0.728
Mar '17 1.46 -0.645
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 9 3.72 17.00 0.00 2.50
Quarter Ending Jun-19 9 3.72 17.00 0.00 2.50
Year Ending Dec-19 10 15.50 68.00 0.00 9.83
Earnings (per share)
Quarter Ending Mar-19 9 -0.70 -0.37 -0.96 -0.77
Quarter Ending Jun-19 9 -0.72 -0.40 -0.97 -0.81
Year Ending Dec-19 10 -2.90 -1.71 -4.04 -3.24
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 33.71
P/E High - Last 5 Yrs. -- 148.01 49.93
P/E Low - Last 5 Yrs. -- 47.79 24.27
Beta -- 1.08 0.90
Price to Sales (TTM) 67.04 49.51 6.28
Price to Book (MRQ) 5.11 10.16 5.27
Price to Tangible Book (MRQ) 5.29 13.82 6.79
Price to Cash Flow (TTM) -- 52.80 24.84
% Owned Institutions 76.00 3.75 1.69

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.40
Dividend Yield - 5 Year Avg -- 0.09 1.42
Dividend 5 Year Growth Rate -- 0.79 4.83
Payout Ratio(TTM) -- 7.04 41.08

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -68.36 130.03 9.72
Sales (TTM) vs TTM 1 Yr. Ago -54.89 47.85 5.87
Sales - 5 Yr. Growth Rate -- 22.76 11.20
EPS (MRQ) vs Qtr. 1 Yr. Ago -96.61 75.87 47.26
EPS (TTM) vs TTM 1 Yr. Ago -81.53 -- --
EPS - 5 Yr. Growth Rate -- 12.03 10.82
Capital Spending - 5 Yr. Growth Rate -- 9.24 15.18

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.26
Current Ratio (MRQ) 12.23 3.43 3.08
LT Debt to Equity (MRQ) 0.00 18.73 11.38
Total Debt to Equity (MRQ) 0.00 31.43 16.13
Interest Coverage (TTM) -- -43.27 29.51

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.29 53.78
Gross Margin - 5 Yr. Avg. -- 60.55 52.17
EBITD Margin (TTM) -713.80 -- --
EBITD - 5 Yr. Avg -- -110.23 12.87
Operating Margin (TTM) -726.43 -184.42 6.20
Operating Margin - 5 Yr. Avg. -- -126.67 8.31
Pre-Tax Margin (TTM) -711.97 -175.20 7.17
Pre-Tax Margin - 5 Yr. Avg. -- -132.83 8.61
Net Profit Margin (TTM) -712.22 -181.93 3.30
Net Profit Margin - 5 Yr. Avg. -- -137.23 4.88
Effective Tax Rate (TTM) -- 21.48 22.88
Effective Tax Rate - 5 Yr. Avg. -- 15.57 23.39

Efficiency

  Company industry sector
Revenue/Employee (TTM) 107,935 7,650,695 844,239,566
Net Income/Employee (TTM) -768,740 652,572 100,064,145
Receivable Turnover (TTM) -- 6.25 5.72
Inventory Turnover (TTM) -- 1.89 3.48
Asset Turnover (TTM) 0.05 0.32 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -32.15 6.45 11.08
Return on Assets - 5 Yr. Avg. -- 5.52 12.21
Return on Investment (TTM) -35.17 8.99 14.48
Return on Investment - 5 Yr. Avg. -- 6.85 15.88
Return on Equity (TTM) -45.36 10.13 15.99
Return on Equity - 5 Yr. Avg. -- 8.39 17.00
  1 Year 3 Year 5 Year
Sales % -17.96 -- --
EPS (TTM) % -6.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Voyager Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 41.95 37.05 99 99
13 Week 121.50 110.71 99 95
26 Week 65.42 52.84 99 98
52 Week 71.16 45.07 99 72
YTD 62.56 42.76 99 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 90.34%
# of Holders: 175
Total Shares Held: 29,411,506
3 Mo. Net Change: 20,740
# New Positions: 1
# Closed Positions: 1
# Increased Positions: 4
# Reduced Positions: 12
# Net Buyers: -8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.